View in EDS PDF Full Text

Slowly Progressing Type 1 Diabetes: Persistence of Islet Cell Autoantibodies is Related to Glibenclamide Treatment.

Saved in:
Bibliographic Details
Title: Slowly Progressing Type 1 Diabetes: Persistence of Islet Cell Autoantibodies is Related to Glibenclamide Treatment.
Authors: Cabrera-Rode, Eduardo1, Perich, Pedro1, Diaz-Horta, Oscar1, Tiberti, Claudio2, Molina, Gisela1, Arranz, Celeste1, Martin, Juana M.1, Licea, Manuel1, De Leiva, Alberto3, Puig-Domingo, Manuel3, Dimario, Umberto2
Source: Autoimmunity. Nov2002, Vol. 35 Issue 7, p469-474. 6p.
Database: Academic Search Ultimate
Description
ISSN:08916934
DOI:10.1080/0891693021000050574